Thus, KIR+CD8+ T cells specifically eliminate gliadin-specific CD4+ T cells from the leukocytes of CeD patients through the recognition of classical and/or nonclassical class I MHC molecules. The gene discussed is HLA-C; the disease is cranioectodermal dysplasia.